Parameters | Myosteatosis negative (n = 122) | Myosteatosis positive (n = 65) | p value |
---|---|---|---|
Preoperative parameters | |||
Age (years) | 66 ± 0.89 | 73 ± 1.22 | < 0.01 |
Sex (male/female) | 93/29 | 47/18 | 0.55 |
BMI | 23.4 ± 0.29 | 24.1 ± 0.40 | 0.16 |
Etiology (HBV・HCV/Others) | 70/52 | 32/33 | 0.28 |
DM (- / +) | 78/44 | 41/24 | 0.51 |
HT (- / +) | 66/56 | 25/40 | 0.07 |
Plt (×104/µL) | 18.2 ± 0.72 | 19.1 ± 0.99 | 0.44 |
T-bil (mg/dL) | 0.86 ± 0.02 | 0.77 ± 0.03 | 0.03 |
Alb (g/ml) | 4.0 ± 0.04 | 3.8 ± 0.05 | 0.02 |
TLC (/µl) | 519 ± 80 | 700 ± 112 | 0.19 |
NLR | 2.51 ± 0.13 | 2.81 ± 0.19 | 0.20 |
ICG R15 (%) | 11.6 ± 0.85 | 14.0 ± 1.16 | 0.10 |
Child-Pugh class (A/B) | 120/2 | 63/2 | 0.73 |
AFP (ng/ml) | 3393 ± 1813 | 5185 ± 2474 | 0.56 |
Tumor factor | |||
Tumor number (Solitary/Multiple) | 95/27 | 53/12 | 0.55 |
Tumor size (cm) | 4.33 ± 0.26 | 4.70 ± 0.35 | 0.40 |
Diff (Well/Mode/Poor) | 17/92/13 | 11/49/5 | 0.04 |
vp (- / +) | 101/21 | 51/14 | 0.47 |
vv (- / +) | 113/9 | 64/1 | 0.06 |
Stage (I/II/III/IV) | 21 / 60 / 34 / 7 | 8 / 35 / 19 / 3 | 0.80 |
Perioperative parameters | |||
Type of surgery (major/minor) | 96/26 | 54/11 | 0.46 |
Operative time (min) | 306 ± 6.2 | 296 ± 8.4 | 0.37 |
Blood loss (ml) | 235 ± 20 | 174 ± 27 | 0.07 |
Postoperative complication (< Grade III / ≥Grade III) | 121/1 | 65/0 | 0.35 |